Samsung Biologics has highlighted its contract development and manufacturing organization, or CDMO, capabilities at Biologics Manufacturing Asia 2026 in Singapore, receiving a bioprocessing excellence award during the two-day event. According to Samsung Biologics on Thursday, the Korean CDMO leader presented its top-notch CDO technologies and services at the conference on Wednesday. Lim Heon-chang, director of formulation development at Samsung Biologics’ CDO division, introduced case studies of

Samsung Biologics and Eli Lilly are partnering to establish a biotech incubator in Incheon, South Korea.

Samsung Biologics has partnered with Eli Lilly to establish an open innovation hub for emerging biotechnology companies in Korea, marking Eli Lilly's first such site outside the United States and China.

Samsung Biologics, Eli Lilly to establish biotech incubator in Incheon  Yonhap News Agency